Abstract
Most prostate cancers are treated, although more than 80% remain clinically insignificant and fewer than 3% are fatal. This retrospective study of 240 radical prostatectomy cases with comprehensive follow-up was a search for reliable markers of prostate cancer prognosis evaluable on biopsy specimens to enable minimization of unnecessary treatment, morbidity, and costs. Representative cancer and benign tissue from each prostatectomy specimen was made into tissue microarrays and stained with antibodies targeting 20 gene sequences. Traditional clinical and pathologic prognosticators and the 20 antibody stains were correlated with patient outcomes. By univariable analysis 4 of 20 antibodies (STMN1/stathmin 1, CYP4Z1/cytochrome p450-4z1, CDH1/E-cadherin, and Hey2), Gleason score, perineural invasion, and apical involvement were statistically significant outcome predictors for biopsy tissue. By multivariate analysis, Gleason score, Hey2, and CYP4Z1 were independently predictive. STMN1 and CDH1 were not independent of Gleason score but remain useful because marker interpretation is objective and Gleason scores often differ for biopsy and prostatectomy specimens.
References
Aug 10, 2004·American Journal of Clinical Pathology·Jeffrey S RossBhaskar V S Kallakury
Jan 8, 2005·Clinical Prostate Cancer·Jonathan L Chin, Robert E Reiter
Oct 29, 2005·Science·Scott A TomlinsArul M Chinnaiyan
Jul 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Brian Z RingDouglas T Ross
Aug 11, 2006·Nature Biotechnology·Lee HartwellElizabeth Swisher
Apr 3, 2007·Nature Genetics·Meredith YeagerGilles Thomas
Apr 3, 2007·Nature Genetics·Christopher A HaimanDavid Reich
Apr 3, 2007·Nature Genetics·Julius GudmundssonKari Stefansson
Apr 27, 2007·Nature Genetics·John S Witte
May 29, 2007·The American Journal of Surgical Pathology·Sven PernerMark A Rubin
Jul 3, 2007·Nature Genetics·Julius GudmundssonKari Stefansson
Aug 3, 2007·Nature·Scott A TomlinsArul M Chinnaiyan
Nov 1, 2007·British Journal of Cancer·R K NamA Seth
Dec 13, 2007·Journal of the National Cancer Institute·David DugganJohn D Carpten
Jan 18, 2008·The New England Journal of Medicine·S Lilly ZhengHenrik Grönberg
Jan 31, 2008·European Journal of Human Genetics : EJHG·Iona ChengJohn S Witte
Feb 12, 2008·Nature Genetics·Gilles ThomasStephen J Chanock
Feb 12, 2008·Nature Genetics·Rosalind A EelesDouglas F Easton
Feb 12, 2008·Nature Genetics·Julius GudmundssonKari Stefansson
Jun 20, 2008·Nature Reviews. Cancer·Chandan Kumar-SinhaArul M Chinnaiyan
Jul 4, 2008·The Journal of Clinical Investigation·Goutham NarlaJohn A Martignetti
Oct 18, 2008·Clinical Chemistry·Girish SardanaEleftherios P Diamandis
Oct 18, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Douglas T RossNorman Wolmark
Mar 17, 2009·The American Journal of Pathology·Yi WangAvraham Raz
Feb 11, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Peter HammarstenAnders Bergh
Mar 5, 2010·CA: a Cancer Journal for Clinicians·Andrew M D WolfUNKNOWN American Cancer Society Prostate Cancer Advisory Committee
Jul 9, 2010·CA: a Cancer Journal for Clinicians·Ahmedin JemalElizabeth Ward
Oct 27, 2010·Journal of Cancer·Chikezie O Madu, Yi Lu
Feb 4, 2011·Nature·Zhihu DingRonald A DePinho
Feb 11, 2011·Nature·Michael F BergerLevi A Garraway
Jun 22, 2011·Cancer·Carrie Printz
Dec 6, 2011·Cancer Discovery·Xiao-Song WangArul M Chinnaiyan
Citations
Dec 7, 2013·Cellular Oncology (Dordrecht)·Yong WuYa Cao
Nov 19, 2013·Oncogene·H C WhitakerD E Neal
Jun 20, 2017·Analytical Chemistry·Jianliang ZhouHui Zhang
Jun 24, 2017·Hormones & Cancer·Cecilia ColomberoSusana Nowicki
Jan 31, 2013·Korean journal of urology·Hyun Wook YouJu Won Lim
Oct 12, 2017·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Matthew G McDonaldAllan E Rettie
Oct 23, 2016·Oncotarget·Dan-Chun WuXu-Hui Liu
May 3, 2013·Molecular Cancer Therapeutics·Sucharita J Mistry, William K Oh
Dec 4, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Shuang G ZhaoFelix Y Feng
Jun 25, 2020·Advanced Drug Delivery Reviews·Patrick M GlassmanVladimir R Muzykantov
Feb 11, 2021·Cancers·Konrad SopylloTuomas Mirtti
Feb 22, 2021·European Journal of Medicinal Chemistry·David MachalzGerhard Wolber
Mar 12, 2021·Scientific Reports·Yousef M Al-SarairehHamzeh M Alrawashdeh
Jul 10, 2021·Bioengineered·Wei ChengLiang Shi